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Abstract
Background: The association of nipple discharge with breast carcinoma has resulted in numerous
women undergoing exploratory surgery to exclude malignancy. The aim of this study was to
determine whether pre-operative factors can identify those patients that are most at risk of
carcinoma.
Methods:  All patients over a 14-year period (1991–2005) who had a microdochectomy or
subareolar exploration for the evaluation of nipple discharge were assessed. Patient characteristics,
pre-operative imaging and pathological findings were analysed.
Results: Of the 211 patients included in this study, 116 patients had pathological (unilateral,
uniductal serous or bloody) discharge. On excision, 6% (n = 7) of patients with pathological
discharge and 2.4% (n = 2) of patients with non-pathological discharge were diagnosed with
carcinoma. Overall, major duct excision resulted in the diagnosis of carcinoma in 4.3% (n = 9),
ADH/LCIS in 4% (n = 8), papilloma in 39% (n = 83), and duct ectasia or non-specific benign disease
in 53% (n = 111) of patients. In the patients determined to have malignancy, 44% (n = 4) were
premenopausal. No patient with a non-bloody discharge in the total population analysed (28%; n =
59/211), or in the population with a pathological discharge (21%; n = 24/116) was found to have
carcinoma upon excision.
Conclusion: Microdochectomy or major duct excision performed for nipple discharge resulted in
a low rate of malignancy on excision. Conservative management of non-bloody nipple discharge can
be considered in patients with no other clinical or radiological signs of malignancy.
Background
The association of pathological (unilateral, uniductal,
spontaneous, serous or bloody) nipple discharge with
breast carcinoma has resulted in numerous women
undergoing exploratory surgery to rule out malignancy.
The association of pathological nipple discharge with
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breast carcinoma is approximately 10–20% [1-7], but it
may be considerably lower in patients with no obvious
clinical or radiological evidence of breast carcinoma, who
are undergoing major duct excision for diagnostic pur-
poses [2,3,8]. This creates a considerable management
challenge for surgeons as approximately 5% of patients
present with discharge as a breast symptom [9-11]. A low
rate of malignancy on excision may not justify routinely
offering diagnostic surgery to all patients presenting with
pathological nipple discharge, unless it is for the purpose
of symptom relief. The ability to identify patients at low
risk of malignancy, who may benefit from conservative
management, would be valuable.
The purpose of this study was to determine the rate of
malignancy following microdochectomy or subareolar
exploration. Additionally, we sought to determine
whether pre-operative risk factors identified those patients
most at risk of malignancy. Finally, we evaluated the accu-
racy of routine preoperative tests in the diagnosis of signif-
icant pathology.
Methods
This study was conducted in St Vincent's University Hos-
pital, a tertiary referral centre for breast surgery. A surgical
operating database, spanning a 14-year period, was que-
ried for all patients who underwent a microdochectomy
or subareolar exploration. This study excluded patients
with a preoperative histological diagnosis that confirmed
carcinoma and patients who did not undergo surgery for
evaluation of nipple discharge. The study was conducted
under the guidelines of the local ethics committee, and in
accordance to the tenets of the Declaration of Helsinki.
All medical records of patients undergoing major duct
excision surgery were reviewed. Data collected included
patient age, menopausal status, nature and duration of
discharge, associated clinical findings, family history of
breast cancer, and findings from any imaging studies per-
formed. In addition, diagnostic methods, operative proce-
dure, and histopathological details were recorded for each
case. Mammography was classified by radiologists using
the BIRAD scale (BIRAD1& 2, benign; BIRAD 3, lesion of
uncertain malignant potential; BIRAD 4, suspicious for
malignancy; BIRAD 5, malignant). Ductograms were not
performed preoperatively. Ultrasonography was intro-
duced into clinical practice in the later years of the study.
The indication for subareolar exploration or microdo-
chectomy in our institution was primarily pathological
discharge. Pathological discharge was defined in this
study as uniductal, unilateral, spontaneous, bloody or
serous discharge. At the discretion of the treating consult-
ant, patients who did not strictly fulfil the criteria for
'pathological' discharge or patients with persistent bother-
some discharge, also underwent surgery. Surgery was per-
formed using a circumareolar incision. In the
microdochectomy procedure, a lacrimal probe was passed
into the affected duct and the duct was excised. In the case
of subareolar exploration, all the ducts behind the nipple
were excised.
Statistical analysis was performed using SPSS (version 11,
Chicago, IL) statistical software. Categorical variables
were compared with Chi Squared Test, or Fishers' Exact
Test (2-tailed), where appropriate. Continuous variables
were analysed with the Mann Whitney U test.
Results
Patients
A total of 211 patients underwent a microdochectomy (n
= 101) or subareolar exploration (n = 110) during the
study period. Of these, 116 patients (55%) had patholog-
ical discharge and 86 patients (41%) had non-pathologi-
cal discharge. There were 9 patients (4%) where
incomplete data prevented categorisation of the nature of
discharge [(spontaneous vs expressed (n = 7) and uniduc-
tal vs. multiductal (n = 5)] and where appropriate, these
patients were excluded from the analysis. The median age
of patients at the time of presentation was 49 years (range
22–78 years) for the total population, and 51 years (range
26–78 years) for patients with evidence of pathological
discharge. Forty five percent of patients (n = 52) with
pathological discharge were less than 50 years of age. Fol-
lowing excision, 4.3% (n = 9) of patients were diagnosed
with malignancy, with a rate of 6% (n = 7) for patients
with pathological discharge, and a rate of 2.4% (n = 2) for
patients with non-pathological discharge.
Discharge characteristics
The characteristics of the nipple discharge in the total pop-
ulation of patients who underwent an operation are
shown in Table 1. Fifty nine patients (28%) were operated
on for non-bloody discharge, 150 patients (71%) for
bloody discharge, and 2 patients (1%) for serosanguinous
discharge. Ninety five percent (n = 200) of patients had
unilateral discharge, 79% (n = 158/201) had uniductal
discharge and 79% (n = 159/202) had spontaneous dis-
charge. Of those with pathological discharge, 21% (n =
24) had serous discharge.
Preoperative examination
A clinical examination was performed on all patients.
Nineteen patients (9%) had an associated palpable abnor-
mality. While 2 of these 19 patients had malignancy, the
lump in these 2 patients was not considered to be clini-
cally suspicious. One of the 19 palpable abnormalities
was considered suspicious for malignancy, but was found
to be benign on excision. Seven patients with malignancy
had no palpable abnormality. The sensitivity of clinicalBMC Cancer 2006, 6:164 http://www.biomedcentral.com/1471-2407/6/164
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examination in this study was therefore determined to be
0%.
Radiology
Mammographic details were available in 181 patients.
171 (94%) of these were benign (classified as BIRAD 1 or
2), 8 mammograms demonstrated definite lesions and 2
mammograms suggested ductal dilatation. No patient
with carcinoma had findings on mammography that were
suspicious for malignancy giving a sensitivity of mam-
mography of 0% in this patient population. A mass or
asymmetrical density was noted in 6 patients. The patho-
logical finding on excision for these patients was papil-
loma (n = 2), and duct ectasia/non-specific findings (n =
4). Ductal dilatation was noted with 2 patients on mam-
mography and papillomas were found on excision in both
cases. Calcification (n = 1) requiring investigation (BIRAD
3 or above) was not associated with any specific findings,
though 5 of the 9 patients with carcinoma had 'benign
breast calcification' (BIRADS 1 or 2). Ultrasonography
was performed on 33 patients. A correct cause of discharge
was identified in only 3 of these patients (papilloma).
Two patients with malignancy underwent ultrasound
examination with non suspicious findings (duct ectasia n
= 1), fibroadenoma n = 2).
Excision pathology
Of the total group, 4.3% (n = 9) of patients were diag-
nosed with carcinoma on excision with a rate of 6% (n =
7) for pathological discharge, and a rate of 2.4% (n = 2)
for non-pathological discharge. Two of the patients with
malignancy were diagnosed with invasive carcinoma, and
7 with ductal carcinoma in situ (DCIS). The excision
pathology findings for all patients are shown in Table 2.
Those with serous discharge were found to have papil-
loma (n = 20), papilloma/atypical ductal hyperplasia
(ADH) (n = 1), ductal ectasia (n = 5) or non-specific find-
ings (n = 7). Patients with green, brown or milky dis-
charge were diagnosed with ductal ectasia/benign breast
findings in 83% (n = 15/18) of cases and papilloma/atyp-
ical papilloma in 17% (n = 3/18) of cases. The most com-
mon finding associated with bloody discharge was
papilloma (41%; n = 61/150).
Patients with malignancy
Data on patients who had a diagnosis of carcinoma fol-
lowing excision are provided in Table 3. Of the 9 patients,
5 underwent a microdochectomy procedure and 4 under-
went a subareolar exploration. Of note, all 9 patients had
bloody nipple discharge. Eighty nine percent (n = 8) had
uniductal discharge and 78% (n = 7) had spontaneous
discharge. There was no significant difference in those
patients with malignancy versus those without, in respect
to age, menopausal status, family history of breast carci-
noma or the use of the oral contraceptive pill or hormone
replacement therapy (Table 3). Forty four percent (n = 4)
of patients with malignancy were pre menopausal.
Table 1: Nature of discharge
Total group
[n = 211(%)]
Non-pathological discharge*
[n = 86 (%)]
Pathological discharge*
[n = 116 (%)]
Bloody 150 (71%) 51 (60%) 91 (78%)
Serosanguinous 2 (1%) 2 (2%)
Non-bloody 59 (28%) 33 (38%) 24 (21%)
Serous 33 (16%) 7 (8%) 24 (21%)
Green 13 (6%) 13 (15%)
Brown 5 (2%) 5 (6%)
Other 8 (4%) 8 (9%)
Unilateral 200 (95%) 75 (87%) 116 (100%)
Bilateral 11 (5%) 11 (13%)
Uniductal 158 (79%)† 38 (47%)† 116 (100%)
Multiductal 43 (21%)† 43 (53%)†
Unspecified 10 5
Spontaneous 159 (79%)† 41 (49%)† 116 (100%)
Expressed 43 (21%)† 43 (51%)†
Unspecified 9 2
*Nine patients could not be classified as either pathological or non-pathological due to unavailable data
† Percentages expressed of available dataBMC Cancer 2006, 6:164 http://www.biomedcentral.com/1471-2407/6/164
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Specific lesions
Table 4 provides data on those patients who had normal
or non-specific findings on excision and compares them
to those with specific findings on excision. Of note,
patients on hormone therapy (hormone replacement
therapy or the oral contraceptive pill) were more likely to
have non-specific findings (p = 0.024) on excision. A dis-
charge colour other than bloody or serous was also asso-
ciated with non-specific findings (p < 0.0001), whereas
serous (p = 0.042) and uniductal disease (p = 0.006) were
associated with specific findings.
Recurrence of symptoms
Eighteen patients (9%) returned to clinic with a recur-
rence of discharge. The median time to recurrence of dis-
charge was 7 months (range 0–5 years). In 12 patients
(6%), the discharge returned within one year.
In addition, 3 patients were later diagnosed with malig-
nancy at our clinic 2, 8 and 9 years following the initial
resection. All three patients originally had bloody dis-
charge, which was not present at the time of diagnosis of
malignancy. However, two of the three patients presented
at that time, with a lump near the nipple.
Discussion
The association of pathological nipple discharge with
malignancy, in a small proportion of patients, results in
numerous women undergoing exploratory surgery to rule
out evidence of serious pathology. Studies assessing path-
ological breast discharge report associated malignancy
rates of up to 20% [1-7,12,13]. Those studies with high
rates of malignancy usually include patients with obvious
radiological malignancy, whose initial operative proce-
dure was a diagnostic excision of a definite breast abnor-
mality. These studies were often conducted prior to an era
of widespread preoperative diagnosis with core biopsy. In
contrast, in this study, we were concerned with the out-
come of patients, who in the absence of an obvious cause
of discharge, underwent major duct excision primarily as
a diagnostic procedure. These patients present a particular
challenge to surgeons and may have a different risk profile
than those patients presenting with a more clinically and
radiologically apparent breast carcinoma, and who also
present with associated discharge.
In the present study of 211 patients, only 4.3% of patients
were diagnosed with breast carcinoma following major
duct excision. This includes a cohort of patients with path-
ological and non-pathological discharge, both of which
were associated with a low risk of carcinoma (6% and
2.3% respectively). Overall, these results emphasise that
the traditionally reported 10–20% rate of breast malig-
nancy [4,6-8,14,15] associated with pathological dis-
charge is not representative of those patients who present
with pathological discharge alone. In a similar patient
population to this study, King et al found only one case of
malignancy out of 39 patients undergoing duct excisions
[16], and in a study by Chaudary et al. [3] on patients
undergoing microdochectomy, the carcinoma rate was
5.9%. Other studies have produced similar results [8,17].
Justification of diagnostic excision where there is such a
low yield of malignancy becomes increasingly difficult,
and emphasises the need for more discriminatory guide-
lines for this particular cohort of patients. In addition, it
must be considered that excision of the ducts may not
yield a diagnosis. In this study, a specific pathological
cause of discharge was not identified in 25% of patients
and in a further 25% 'duct ectasia/duct dilatation' was the
only pathological finding. Our findings indicate that duct
excision, used as a diagnostic test, has a sensitivity in the
region of 50–75%. There is increasing evidence that a con-
siderable number of pathological lesions are not located
in close enough proximity to the nipple for a surgical duct
excision to adequately locate them [5,18-20], which may
further explain this low diagnostic yield.
Table 2: Pathological findings on excision
Total group
[n = 211]
Non pathological 
discharge*
[n = 86]
Pathological 
discharge*
[n = 116]
Bloody discharge
[n = 152]
Non bloody discharge
[n = 59]
Papilloma 81 (38%) 26 (30%) 52 (45%) 59 (39%) 22 (37%)
Papilloma and ADH/
atypical papilloma
5 (2%) 3 (3%) 2 (2%) 2 (1%) 3 (5%)
ADH/LCIS† 5 (2%) 2 (2%) 3 (3%) 5 (3%) 0 (0%)
Carcinoma 9 (4.3%) 2 (2%) 7 (6%) 9 (6%) 0 (0%)
Duct ectasia 51 (24%) 24 (28%) 25 (22%) 34 (22%) 17 (29%)
Benign/non-specific 
findings
60 (28%) 29 (34%) 27 (23%) 43 (28%) 17 (29%)
Abbreviations: ADH = atypical ductal hyperplasia; LCIS = lobular carcinoma in situ
† LCIS was of the 'classical' variant
*Nine patients could not be classified as either pathological or non-pathological dischargeBMC Cancer 2006, 6:164 http://www.biomedcentral.com/1471-2407/6/164
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The low rate of malignancy underpins the difficulty in
identifying those patients most at risk of carcinoma. How-
ever, an important finding of this 14-year study was that
none of the 59 patients who were operated on for a non-
bloody discharge had malignancy on excision. The results
of this study suggest that patients with a non-bloody dis-
charge, who have no obvious clinical or radiological signs,
are at low risk of malignancy. While there is certainly an
association between non-bloody discharge and breast car-
cinoma [5,13,15,21], this association is more readily
apparent in studies of patients with obvious breast abnor-
malities. In studies focusing on patients undergoing
microdochectomies, whose indication for operation is for
discharge alone, the clinical presentation appears to be
different. A study by Chaudary et al. [3] on patients under-
going microdochectomy, with no associated lump,
revealed that 5.9% were diagnosed with carcinoma. In
that study, only two of the 16 patients who were diag-
nosed with carcinoma had serous discharge, but even
these were hemoccult positive. In the study by Welch et al.
[22], 14 of 16 patients diagnosed with carcinoma follow-
ing microdochectomy had a bloody discharge. In other
studies with this type of patient population, there is either
no association [17], or a very low association [2,18,23]
with carcinoma and non-bloody discharge. Occasionally,
there are exceptions to these findings [5,13,24] such as in
the study by Hou et al. [5], reporting on a Taiwanese pop-
ulation with a very high rate of carcinoma (20%) and an
association with serous discharge, or the study by Sharma
et al [13] demonstrating the association of carcinoma
Table 3: Patient characteristics of those with malignant histology versus those without.
Patients with Malignant Lesions
[n = 9]
Patients with non-malignant lesions
[n = 202]
P-value
Median age (range) 54 (45–75) 49 (22–78) 0.32
Family history 3 (33%) 33/199† (17%) 0.19
Hormone replacement therapy/
oral contraceptive use
1 (11%) 55/188† (29%) 0.45
Premenopausal 4 (44%) 104 (51%)† 0.7
Associated lump 2 (22%) 17 (8%) 0.19
Discharge colour
Serous 0 (0%) 33 (16%) 0.36
Bloody 9 (100%) 141 (70%) 0.06
Serosanguinous 0 (0%) 2 (1%) 1
Other 0 (0%) 26 (13%) 0.6
Brown 0 (0%) 5 (2%) 1
Milky/pus 0 (0%) 8 (4%) 1
Green 0 (0%) 13 (6%) 1
Unilateral 9 (100%) 191 (95%) 1
Bilateral 0 (0%) 11 (5%) 1
Uniductal 8 (89%) 150 (78%)† 0.45
Multiductal 1 (11%) 42 (22%) 0.45
Unspecified 10
Spontaneous 7 (78%) 152 (79%) 1
Expressed 2 (22%) 41 (21%) 1
Unspecified 9
Radiology
Mammography n = 9 n = 172
Normal/benign findings (BIRADS 1 
or 2)
9 (100%) 164 (95%) 1
Abnormal findings (BIRADS 3–5) 0 (0%) 8 (5%) 1
Ultrasound n = 2 n = 31
Normal findings (BIRADS 1–2) 1 (50%) 26 (84%) 0.3
Abnormal findings (BIRADS 3–5) 1 (50%)* 5 (16%) 0.3
†Percentages are expressed of available data
* 'Fibroadenoma'BMC Cancer 2006, 6:164 http://www.biomedcentral.com/1471-2407/6/164
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even with brown or purulent discharge. Essentially, how-
ever, it may be that small, sub-clinical cancers are more
commonly associated with bloody discharge. In a patient
population of this type, whose risk of carcinoma is typi-
cally low (approximately 5%), the evidence suggests that
those with a non-bloody discharge are at particularly low
risk, with a probable overall risk of malignancy of less
than 1 or 2%. To put this in perspective, in the U.S.
patients with mammographic lesions do not undergo
(pre-operative) biopsy if their risk of malignancy, radio-
logically, is considered to be less than 2% [25] (BI-RADS
3). Therefore, it could be argued that this low risk sub-
group with non-bloody discharge may also be monitored
safely.
In this study, we also analysed those who had a specific
cause for discharge identified following excision, and
compared them to those with non-specific or normal
findings. It was of interest, that patients on hormone ther-
apy were found to be more at risk of non-specific findings
on excision. Not surprisingly, discharge of a colour other
than bloody or serous, was associated with non-specific
disease, whereas serous discharge was associated with spe-
cific lesions. All the specific lesions in patients with serous
discharge were papillomas including one case of papil-
loma and ADH. Currently, there is no consensus as to
whether papillomas pose a significant risk of carcinoma
or whether they should be removed [26-28]. Certainly,
the finding that uniductal, as well as serous discharge, was
associated with specific lesions supports the use of the
term 'pathological' discharge in this category.
In the present study, the efficacy of various clinical param-
eters and tests were also analysed. While clinical history
Table 4: Patient characteristics in those with specific lesions on excision versus those with non-specific findings or duct ectasia.
Non-specifc findings/Duct ectasia
[n = 111]
Specific Lesion
[n = 100]
P-value
Median age (range) 49 (22–78) 49 (26–75) 0.7
Family history 17/108 (16%) 20/97 (21%) 0.37
Hormone replacement therapy/
oral contraceptive use
36/101 (36%) 20/95 (21%) 0.024
Premenopausal 56(50%) 52 (52%)† 0.86
Associated lump 10/109 (9%) 9/99 (9%) 0.98
Discharge colour
Serous 12 (11%) 21 (21%) 0.042
Bloody 77 (69%) 75 (75%) 0.36
Other 22 (20%) 4 (4%) <0.001
Brown 4 (4%) 1 (1%) 0.37
Milky/pus 7 (6%) 1 (1%) 0.068
Green 11 (10%) 2 (2%) 0.017
Unilateral 103 (93%) 97 (97%) 0.17
Bilateral 8 (7%) 3 (3%) 0.17
Uniductal 73 (66%) 85 (85%) 0.006
Multiductal 30 (27%) 13 (13%) 0.006
Unspecified 8 (7%) 2 (2%)
Spontaneous 85 (77%) 74 (74%) 0.59
Expressed 21(19%) 22 (22%) 0.59
Unspecified 5 (5%) 4 (4%)
Radiology
Mammography n = 94 n = 87
Normal/benign findings (BIRADS 1 
or 2)
88 (94%) 85 (98%) 0.28
Abnormal findings (BIRADS 3–5) 6 (6%) 2 (2%) 0.28
Ultrasound n = 16 n = 17
Normal findings (BIRADS 1–2) 15 (94%) 12 (71%) 0.18
Abnormal findings (BIRADS 3–5) 1 (6%) 5 (29%) 0.18BMC Cancer 2006, 6:164 http://www.biomedcentral.com/1471-2407/6/164
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was the most useful indicator of risk with regard to the
nature of discharge, age and menopausal status were of
limited value. Forty four percent of patients diagnosed
with carcinoma were under the age of 50, and were pre-
menopausal. This contrasts with the findings of Lau et al.
[23], who reported that 10 of 11 patients with cancer were
postmenopausal and who subsequently recommended
excision in all postmenopausal women with pathological
discharge. Clinical examination was also found not to be
discriminatory, most likely because patients with suspi-
cious palpable abnormalities would have undergone a
different procedure or would have had a preoperative his-
tological diagnosis. All the patients with carcinoma in this
study, even those with an associated palpable abnormal-
ity, were not considered suspicious on clinical examina-
tion.
Imaging in this study was also found to be unreliable.
Only 9 mammograms demonstrated any abnormality and
there were 8 false-negative mammograms. Ultrasound
performed on 33 patients identified a cause of discharge
in only 3 of the patients. The 2 patients with carcinoma
who underwent an ultrasound examination were not
diagnosed pre-operatively. The poor sensitivity of radiol-
ogy, in this patient setting, is a reflection of higher pre-
operative diagnosis rates. The more widespread use of
core biopsies means that there are considerably less
patients undergoing exploratory surgery for lesions visible
on mammography. This change in practice is reflected by
our high rate of false-negative mammography in diagnos-
tic surgery and our very low overall malignancy rate. How-
ever, these results do suggest that routine ultrasonography
of the retroareolar region, in the absence of mammo-
graphic abnormalities is of limited value.
Other potential pre-operative tests such as ductography
(galactography) or ductoscopy are not performed in our
unit. Ductography was introduced over 60 years ago [29],
but has not become standard practice in many parts of the
world [6,30,31]. It has not proved to be very effective at
discriminating between benign and malignant lesions,
and a negative test does not exclude malignancy [1]. Like-
wise, ductoscopy is also limited by its low specificity [18].
Despite these disadvantages, ductoscopy and ductography
appear to play an important role in guiding a more con-
servative excision or in localising lesions at some distance
from the nipple [18,19]. Several studies have indicated
that lesions are frequently found at some distance from
the nipple orifice [5,18-20,32]. More disturbingly, Hou et
al. [5] reported that 70% of patients with carcinoma pre-
senting with discharge had their lesions located > 2 cm
from the nipple [5].
These studies imply the need for localisation techniques.
Localisation of lesions appears to be most effective if done
at the time of operation. In a study by Cabioglu et al [7]
most patients had preoperative ductography performed.
However it was patients who underwent a ductography
guided operation or that had a localising study at the time
of operation, who where significantly more likely to have
a specific underlying lesion identified, as compared to
patients who underwent a central duct excision alone.
Similarly, Van Zee et al. [33] demonstrated the value of
immediate preoperative ductography in identifying spe-
cific lesions, though a more recent study suggested that
localisation through means of ductoscopy guided ductal
excision may not be as effective [19]. Our study had a high
rate of non-specific or benign findings on excision, indi-
cating that a surgical procedure alone may not be ade-
quate as a diagnostic tool. Increasing interest into more
accurate techniques to identify lesions, including the use
of thinner more flexible fiberoptics ductoscopy [34] may
enhance the value of surgical excision.
Conclusion
In this study, patients undergoing major duct excision for
evaluation of pathological nipple discharge had a low rate
of malignancy on excision. This low rate of malignancy,
coupled with the finding that no patient operated on in
the 14-year period for non-bloody discharge had malig-
nancy on excision, suggests that a conservative approach
may be considered in patients with non-bloody discharge.
The results of our study also suggest that patient age is not
helpful in identifying those at risk of malignancy follow-
ing major duct excision, and that major duct excision has
limitations as a diagnostic tool.
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